New Frontiers in Schizophrenia Treatment Beyond Dopamine Check out our extensive video library (see channel for our latest videos) Abstract For more than six decades, the treatment of schizophrenia has been dominated by dopamine-blocking antipsychotic medications. While this approach has transformed the management of psychotic symptoms such as
Psychiatry
Psychiatry’s Role in the Obesity Epidemic
Alternative Therapies for Depression: Breakthrough Neurostimulation Methods Show 80% Success Rate
Alternative Therapies for Depression: Breakthrough Neurostimulation Methods Show 80 Percent Success Rate Check out our extensive video library (see channel for our latest videos) Introduction Alternative therapies for depression have gained crucial importance as traditional antidepressant medications relieve symptoms in only about one-third of
Psychedelics for Acute Suicidality: Could the ED Become the Frontline?
Psychedelics for Acute Suicidality Could the ED Become the Frontline Abstract This paper examines the emerging role of psychedelic medications as potential therapeutic agents for acute suicidal ideation and behavior in emergency department settings. Suicide rates have risen steadily over the past decade, and current acute-care interventions such as pharmacotherapy,
Screen Time, Social Media, and Teen Mental Health: What Can Family Physicians Do?
Screen Time, Social Media, and Teen Mental Health - What Can Family Physicians Do Abstract Adolescent mental health has become a critical focus in both clinical practice and public health discussions. The rising prevalence of anxiety, depression, sleep disturbances, attention difficulties, and self-harm behaviors among teenagers has intensified concern
Should Family Physicians Routinely Screen for Depression and Anxiety?
Should Family Physicians Routinely Screen for Depression and Anxiety Abstract This paper evaluates whether family physicians should implement routine screening for depression and anxiety among all adult patients, including those who do not present with explicit mental health complaints. Depression and anxiety remain among the most prevalent non-communicable conditions
Psychedelic Therapy in 2025 -New Research Reveals Surprising Clinical Outcomes
Psychedelic Therapy in 2025 New Research Reveals Surprising Clinical Outcomes Introduction Psychedelic therapy is transforming mental health treatment with remarkable clinical outcomes across multiple conditions. Recent studies show that MDMA-assisted psychotherapy produces lasting symptom relief in 71% of veterans and first responders with
Neuroinflammation in Depression: Biomarker or Target?
Neuroinflammation in Depression: Biomarker or Target? Abstract Major depressive disorder (MDD) remains a leading global cause of disability, yet its underlying pathophysiology is incompletely understood. Increasing evidence implicates immune and inflammatory processes in the onset, progression, and treatment response of depression. This review synthesizes current
Managing Anxiety and Depression Without a Psychiatrist: Primary Care’s Expanding Mental Health Burden
Managing Anxiety and Depression Without a Psychiatrist: Primary Care’s Expanding Mental Health Burden Abstract Purpose:This study examines the evolving role of primary care in addressing the growing burden of anxiety and depression, particularly in the context of an ongoing and severe shortage of mental health
